Individuals Stopping Weight-Loss Injections Put On Pounds Far More Rapidly Than Dieters

New research reveals that individuals who come off blockbuster slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who halt conventional lifestyle regimens.

Published data in a leading health publication demonstrates that while obese people frequently drop a large proportion of their body weight while on the medication, the mass is regained at an average rate of nearly a kilo each month after stopping.

"People using such drugs must be aware of the danger of fast weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.

Such speed of recovery implies a return to starting weight in about a year and a half.

Weighing Approaches

The research, which looked at dozens of trials involving over 9,000 of participants, contrasted the results of these new drugs with conventional dieting.

The team note that individuals who lose weight through lifestyle changes alone typically see a slower creep back—around 0.1 kg a month—after stopping.

Explaining the Rapid Rebound

Nutrition scientists believe the mode of action of the drugs explains the heightened regain.

GLP-1 drugs copy a natural hormone called GLP-1, which moderates feelings of fullness.

"Long-term administration of GLP-1 concentrations far above than normal may cause the body to generate a reduced amount of its endogenous hormone, and may also diminish sensitivity to its effects," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means hunger is uncontrolled, making binge eating much more probable."

A Chronic Condition?

Medical guidelines recommend the jabs for people with obesity-related health risks, accompanied by recommended lifestyle changes.

Many experts say that, considering the high risk of relapse, the therapy should be considered life-long.

This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the long-term character of obesity," similar to managing diseases like high blood pressure.

Patient Accounts

People who have come off the medication describe a sudden return of appetite.

"It was like something activating and you're instantly extremely hungry," said an individual.

This difficulty is exacerbated if individuals have not adopted permanent dietary or behavioural modifications during therapy.

Significant Interest

Recent estimates indicate that a significant number of adults in the UK have used these injections in the past year, with demand continuing to grow.

• Use is greater among women compared to men.
• The 40s and 50s demographic shows the highest usage rates.
• Many access the medications through private healthcare rather than the NHS.

Ultimately, clinicians stress that while these medications are potent agents for weight loss, they are not a standalone cure and lasting health benefits relies on integrated lifestyle support.